These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8809644)

  • 41. Changes in clearance of sodium valproate with changes in dose.
    Kilpatrick CJ; Bury RW; Fullinfaw RO; Moulds RF
    Clin Exp Neurol; 1987; 24():97-103. PubMed ID: 3151881
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nicotine diminishes anticonvulsant activity of antiepileptic drugs in mice.
    Czuczwar M; Kiś J; Czuczwar P; Wielosz M; Turski W
    Pol J Pharmacol; 2003; 55(5):799-802. PubMed ID: 14704477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute and chronic treatment with mianserin differentially affects the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock model.
    Borowicz KK; Banach M; Zarczuk R; Lukasik D; Luszczki JJ; Czuczwar SJ
    Psychopharmacology (Berl); 2007 Dec; 195(2):167-74. PubMed ID: 17653694
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetic interaction of zonisamide in rats. Effect of zonisamide on other antiepileptics.
    Kimura M; Tanaka N; Kimura Y; Miyake K; Kitaura T; Fukuchi H
    Biol Pharm Bull; 1993 Jul; 16(7):722-5. PubMed ID: 8401412
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Developmental and therapeutic pharmacology of antiepileptic drugs.
    Miura H
    Jpn J Psychiatry Neurol; 1993 Jun; 47(2):169-74. PubMed ID: 8271538
    [No Abstract]   [Full Text] [Related]  

  • 46. Phenobarbital pharmacokinetics in old age: a case-matched evaluation based on therapeutic drug monitoring data.
    Messina S; Battino D; Croci D; Mamoli D; Ratti S; Perucca E
    Epilepsia; 2005 Mar; 46(3):372-7. PubMed ID: 15730534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validation of a quick modeling program generating clearance estimates at steady state for routine therapeutic drug monitoring.
    el Battah A; Beglia S; Alric R
    Ther Drug Monit; 1995 Aug; 17(4):348-55. PubMed ID: 7482688
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preliminary study of the association between the elimination parameters of phenytoin and phenobarbital.
    Methaneethorn J; Panomvana D; Vachirayonstien T
    Drug Metab Pers Ther; 2017 Sep; 32(3):151-156. PubMed ID: 28873066
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetic evaluation of sustained release formulations of antiepileptic drugs. Clinical implications.
    Bialer M
    Clin Pharmacokinet; 1992 Jan; 22(1):11-21. PubMed ID: 1559305
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of treatment and additional disease on pharmacokinetic of valproic acid in children with epilepsy.
    Juárez-Olguín H; Lugo-Goytia G; Flores-Murrieta F; Ruiz-García M; Lares Asseff I; Flores Pérez J
    Rev Invest Clin; 2010; 62(6):516-23. PubMed ID: 21416779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Usefulness of salivary drug monitoring for detecting efflux transporter overexpression.
    Fagiolino P; Vázquez M; Maldonado C; Ruiz ME; Volonté MG; Orozco-Suárez S; Lazarowski A
    Curr Pharm Des; 2013; 19(38):6701-8. PubMed ID: 23530513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetic interactions of topiramate.
    Bialer M; Doose DR; Murthy B; Curtin C; Wang SS; Twyman RE; Schwabe S
    Clin Pharmacokinet; 2004; 43(12):763-80. PubMed ID: 15355124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of antiepileptic drugs in elderly nursing home residents.
    Birnbaum AK
    Int Rev Neurobiol; 2007; 81():211-20. PubMed ID: 17433926
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come?
    Perucca E; Johannessen SI
    Epileptic Disord; 2003 May; 5 Suppl 1():S17-26. PubMed ID: 12915337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of anticonvulsants in pregnancy: alterations in plasma protein binding.
    Yerby MS; Friel PN; McCormick K; Koerner M; Van Allen M; Leavitt AM; Sells CJ; Yerby JA
    Epilepsy Res; 1990 Apr; 5(3):223-8. PubMed ID: 2384078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Daily salivary anticonvulsant monitoring in patients with intractable epilepsy.
    Herkes GK; Eadie MJ
    Clin Exp Neurol; 1989; 26():141-9. PubMed ID: 2642124
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients.
    EL Desoky ES; Fuseau E; EL Din Amry S; Cosson V
    Eur J Clin Pharmacol; 2004 Jan; 59(11):783-90. PubMed ID: 14673555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pharmacokinetic results of some antiepileptics].
    Capone D; Del Rio A; Campanella G; De Marino V; Pisanti N
    Boll Soc Ital Biol Sper; 1988 Jan; 64(1):17-23. PubMed ID: 3139016
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of discontinuation of phenytoin, carbamazepine, and valproate on concomitant antiepileptic medication.
    Duncan JS; Patsalos PN; Shorvon SD
    Epilepsia; 1991; 32(1):101-15. PubMed ID: 1985818
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum aspirin-esterase activity in epileptic patients receiving treatment with phenobarbital, phenytoin, carbamazepine and valproic acid.
    Puche E; Garcia de la Serrana H; Mota C; Saucedo R
    Int J Clin Pharmacol Res; 1989; 9(1):55-8. PubMed ID: 2496043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.